Cardiolipin composition correlates with prostate cancer cell proliferation

Molecular and Cellular Biochemistry

Volumn 410, Issue 1-2, 2015, Pages 175-185

  Sapandowski, Anja ^a   Stope, Matthias ^b   Evert, Katja ^b   Evert, Matthias ^b   Zimmermann, Uwe ^b   Peter, Daniela ^a   Päge, Ilona ^a   Burchardt, Martin ^b   Schild, Lorenz ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Cardiolipin; Free fatty acids; Lipidomic analysis; Prostate cancer; Tumour cell proliferation

Indexed keywords

CARDIOLIPIN; OLEIC ACID; PALMITOLEIC ACID; FATTY ACID;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DECELERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPIDOMICS; MALE; MASS SPECTROMETRY; MTT ASSAY; PROSTATE CANCER; PROSTATECTOMY; THAWING; AGED; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

AGED; CARDIOLIPINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; TANDEM MASS SPECTROMETRY; TUMOR MICROENVIRONMENT;

EID: 84946481923     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2549-1     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. Cancer J Clin 63:11–30
2. Chan JM, Van Blarigan EL, Kenfield SA (2014) What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol 24:318–323
3. Shimizu H, Ross RK, Bernstein L, Yantani R, Henderson BE, Mack TM (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles Country. Br J Cancer 63:963–966
4. Zhu Y, Wang HK, Qu YY, Ye DW (2015) Prostate cancer in East Asia: evolving trend over the last decade. Asian J Androl 17:48–57
5. Mandair D, Rossi RE, Pericleous M, Whyand T, Caplin ME (2014) Prostate cancer and the influence of dietary factors and supplements: a systematic review. NutrMetab (Lond) 11:30
6. Hardy S, El-Assaad W, Przybytkowski E et al (2003) Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 278:31861–31870
7. Murray M, Hraiki A, Bebawy M, Pazderka C, Rawling T (2015) Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs. Pharmacol Ther 150:109–128
8. Schild L, Lendeckel U, Gardemann A, Wiswedel I, Schmidt CA, Wolke C, Walther R, Grabarczyk P, Busemann C (2012) Composition of molecular cardiolipin species correlates with proliferation of lymphocytes. Exp Biol Med (Maywood) 237:372–379
9. Ponisovskiy MR (2011) Warburg effect mechanism as the target for theoretical substantiation of a new potential cancer treatment. Crit Rev Eukaryot Gene Expr 21:13–28
10. 2+ in mitochondrial dysfunction and disease. Cell Calcium 45:643–650
11. Claypool SM, Koehler CM (2012) The complexity of cardiolipin in health and disease. Trends Biochem Sci 37:32–41
12. Warburg O (1956) On the origin of cancer cells. Science 123:309–314
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
14. Musser DA, Oseroff AR (1994) The use of tetrazolium salts to determinate sites of damage to the mitochondrial electron transport chain in intact cells following in vivo photodynamic therapy with photophrine H. Photochem Photobiol 59:621–626
15. Stope MB, Sauermann A, Rönnau C, Zimmermann U, Walther R, Burchardt M (2012) Androgen receptor and heat shock proteins in progression of prostate cancer cells. Int J Clin Pharmacol Ther 50:65–67
16. RomijnVerkoelen JC, RomijnVerkoelen CF, Schroeder FH (1988) Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 12:99–110
17. Kwan HY, Chao X, Su T, Fu X, Liu B, Tse AK, Fong WF, Yu Z (2014) Dietary lipids and adipocytes: potential therapeutic targets in cancers. J Nutr Biochem S0955–2863(14):00239–00243. doi:10.1016/jjnutbio.2014.11.001
18. Oh YS (2015) Mechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids. Anat Cell Biol 48:16–24
19. de Jong AJ, Kloppenburg M, Toes RE, Ioan-Facsinay A (2014) Fattyacids, lipid mediators, and T-cell function. Front Immunol 13(5):483
20. Jackson MD, Walker SP, Simpson-Smith CM, Lindsay CM, Smith G, Mc Fartane-Anderson N, Bennett FI, Coard KC, Aiken WD, Tulloch T, Paul TJ, Wan RL (2012) Association of whole-blood fatta acids and dietary intakes with prostate cancer in Jamaica. Cancer Causes Control 23:23–33
21. Moreel X, Allaire J, Leer C, Caron A, Labonte ME, Lamarche B, Julien P, Desmeules P, Têtu B, Fradet V (2014) Prostatic and dietary omega-3-fatty acids and prostate cancer progression during active surveillance. Cancer Prev Res (Phila) 7:766–776
22. Eser PO, VandenHeuvel JP, Jl Araujo, Thompson JT (2013) Marine- and plant-derived omega-3 fatty acids differentially regulate prostate cancer cell proliferation. Mol Clin Oncol 1:444–452
23. Hopperton KE, Duncan RE, Bazinet RP, Archer MC (2014) Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity. Exp Cell Res 320:302–310
24. Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 49:364–373
25. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J274:1393–1418
26. Raja V, Greenberg ML (2014) The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype. Chem Phys Lipids 179:49–56
27. Schug ZT, Frezza C, Galbraith LC, Gottlieb E (2012) The music of lipids: how lipid composition orchestrates cellular behaviour. Acta Oncol 51:301–310
28. Ralph SJ, Low P, Dong I, Lawen A, Neuzil J (2006) Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents. Recent Pat Anticancer Drug Discov 1:327–346
29. Ren M, Phoon CK, Schlame M (2014) Metabolism and function of mitochondrialcardiolipin. Prog Lipid Res 55:1–16
30. Sinha F, Das J, Pal PB, Sil PC (2013) Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87:1157–1180
31. Manda G, Isvoranu G, Comanescu MV, Manea A, DebelecButuner B, Korkmaz KS (2015) The redox biology network in cancer pathophysiology and therapeutics. Redox Biol 25:347–357